| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1146/ANNUREV.NUTR.22.010402.102808 |
| P698 | PubMed publication ID | 12055342 |
| P50 | author | Johan Auwerx | Q28468898 |
| P2093 | author name string | Frédéric Picard | |
| P2860 | cites work | Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension | Q22011018 |
| Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators | Q28143758 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 167-197 | |
| P577 | publication date | 2002-01-04 | |
| P1433 | published in | Annual Review of Nutrition | Q4769675 |
| P1476 | title | PPAR(gamma) and glucose homeostasis | |
| P478 | volume | 22 |
| Q27677636 | (+)-Rutamarin as a Dual Inducer of Both GLUT4 Translocation and Expression Efficiently Ameliorates Glucose Homeostasis in Insulin-Resistant Mice |
| Q55073632 | A PPARγ, NF-κB and AMPK-dependent mechanism may be involved in the beneficial effects of curcumin in the diabetic db/db mice liver. |
| Q35072984 | A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA" |
| Q35009877 | A small volatile bacterial molecule triggers mitochondrial dysfunction in murine skeletal muscle |
| Q64057208 | Abdominal Fat SIRT6 Expression and Its Relationship with Inflammatory and Metabolic Pathways in Pre-Diabetic Overweight Patients |
| Q44980680 | Actions of PPARgamma agonism on adipose tissue remodeling, insulin sensitivity, and lipemia in absence of glucocorticoids. |
| Q47952464 | Activation of peroxisome proliferator-activated receptor γ prolongs islet allograft survival |
| Q40256198 | Altered PPARgamma expression inhibits myogenic differentiation in C2C12 skeletal muscle cells |
| Q28075617 | Alzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and Gamma |
| Q39483579 | Angiotensin II receptor blockade and insulin sensitivity in overweight and obese adults with elevated blood pressure |
| Q83319006 | Anti-inflammatory and anti-hyperlipidemic effect of Semecarpus anacardium in a high fat diet: STZ-induced type 2 diabetic rat model |
| Q91896482 | Antimetabolic Syndrome Effect of Phytosome Containing the Combined Extracts of Mulberry and Ginger in an Animal Model of Metabolic Syndrome |
| Q36142671 | Association of NCOA3 polymorphisms with Dyslipidemia in the Chinese Han population |
| Q73568159 | Benzoxazinones as PPARgamma agonists. part 1: SAR of three aromatic regions |
| Q37200544 | Beyond the classic angiotensin-receptor-blocker profile |
| Q42812731 | Caspase-mediated degradation of PPARgamma proteins in adipocytes |
| Q38809993 | Chemical and Physical Approaches to Extend the Replicative and Differentiation Potential of Stem Cells |
| Q34386587 | Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderly |
| Q45183730 | Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial |
| Q39367068 | Comparative molecular profiling of the PPARα/γ activator aleglitazar: PPAR selectivity, activity and interaction with cofactors |
| Q41851511 | Comparative prophylactic effects of α-eleostearic acid rich nano and conventional emulsions in induced diabetic rats. |
| Q33717836 | Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice |
| Q34195708 | Conjugated Linoleic Acid in Humans: Regulation of Adiposity and Insulin Sensitivity |
| Q34427072 | Coronary microvascular dysfunction in diabetes mellitus: A review |
| Q58699640 | Curcumin, Cardiometabolic Health and Dementia |
| Q56378075 | Daily Rhythms of TNFα Expression and Food Intake Regulate Synchrony of Plasmodium Stages with the Host Circadian Cycle |
| Q34197789 | Developmental programming: differential effects of prenatal testosterone excess on insulin target tissues |
| Q37973874 | Does interference with the renin-angiotensin system protect against diabetes? Evidence and mechanisms |
| Q47368574 | ESR1, FTO, and UCP2 genes interact with bariatric surgery affecting weight loss and glycemic control in severely obese patients. |
| Q46124638 | Effect of BSA-induced ER stress on SGLT protein expression levels and alpha-MG uptake in renal proximal tubule cells |
| Q36820428 | Effect of Opuntia humifusa supplementation and acute exercise on insulin sensitivity and associations with PPAR-γ and PGC-1α protein expression in skeletal muscle of rats |
| Q46906733 | Effect of alpha-tocopherol and beta-carotene supplementation on the incidence of type 2 diabetes |
| Q43247258 | Effect of peroxisome proliferator-activated receptor gamma agonists on myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts |
| Q36642651 | Effective treatment of hypertension by AT(1) receptor antagonism: the past and future of telmisartan |
| Q35498269 | Effects of CP-900691, a novel peroxisome proliferator-activated receptor α, agonist on diabetic nephropathy in the BTBR ob/ob mouse |
| Q46293996 | Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease |
| Q33727061 | Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus |
| Q36905154 | Effects of thiazolidinediones on blood pressure |
| Q36556337 | Electroacupuncture Reduces Weight Gain Induced by Rosiglitazone through PPARγ and Leptin Receptor in CNS |
| Q34166268 | Enhanced bone formation in lipodystrophic PPARgamma(hyp/hyp) mice relocates haematopoiesis to the spleen |
| Q44559508 | Enhancement of BRCA1 gene expression by the peroxisome proliferator-activated receptor gamma in the MCF-7 breast cancer cell line |
| Q38058381 | Examining the safety of PPAR agonists - current trends and future prospects |
| Q37106685 | Expression of peroxisome proliferator-activated receptor-gamma in key neuronal subsets regulating glucose metabolism and energy homeostasis |
| Q43165737 | Fasting promotes the expression of SIRT1, an NAD+ -dependent protein deacetylase, via activation of PPARalpha in mice. |
| Q37662234 | Fetal growth restriction, catch-up growth and the early origins of insulin resistance and visceral obesity. |
| Q38516045 | Functional genomic analysis reveals cross-talk between peroxisome proliferator-activated receptor gamma and calcium signaling in human colorectal cancer cells |
| Q36476832 | Gender, body mass index, and PPARγ polymorphism are good indicators in hyperuricemia prediction for Han Chinese |
| Q33902018 | Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndrome |
| Q36846922 | Genomic profiling in nuclear receptor-mediated toxicity |
| Q36447407 | Human immunodeficiency virus (HIV)-1 viral protein R suppresses transcriptional activity of peroxisome proliferator-activated receptor {gamma} and inhibits adipocyte differentiation: implications for HIV-associated lipodystrophy |
| Q39150404 | Hypoxia downregulates PPARγ via an ERK1/2-NF-κB-Nox4-dependent mechanism in human pulmonary artery smooth muscle cells |
| Q24629323 | Hypoxia-inducible factors and the response to hypoxic stress |
| Q35237706 | Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis |
| Q38300981 | Improvement of metabolic syndrome by irbesartan via the PPARγ/HGF pathway in apolipoprotein E knockout mice |
| Q36973729 | In vivo and in vitro studies of a functional peroxisome proliferator-activated receptor gamma response element in the mouse pdx-1 promoter |
| Q90274032 | Induction of peroxisome proliferator activated receptor γ (PPARγ) mediated gene expression and inhibition of induced nitric oxide production by Maerua subcordata (Gilg) DeWolf |
| Q39030513 | Integrated proteomic and metabolomic analysis to assess the effects of pure and benzo[a]pyrene-loaded carbon black particles on energy metabolism and motility in the human endothelial cell line EA.hy926. |
| Q39180889 | Interactions between PPAR Gamma and the Canonical Wnt/Beta-Catenin Pathway in Type 2 Diabetes and Colon Cancer. |
| Q36512559 | Investigational PPAR-gamma agonists for the treatment of Type 2 diabetes |
| Q35753591 | Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients |
| Q36267934 | Is there an estrogenic component in the metabolic syndrome? |
| Q38205763 | Knockout mouse models of insulin signaling: Relevance past and future |
| Q93090203 | Label-free quantitative proteomics identifies transforming growth factor β1 (TGF-β1) as an inhibitor of adipogenic transformation in OP9-DL1 cells and primary thymic stromal cells |
| Q34835012 | Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes |
| Q34216543 | Lysophosphatidic acid signaling: how a small lipid does big things |
| Q33642155 | MBX-102/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema |
| Q35794061 | Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones |
| Q37008855 | Macrophage peroxisome proliferator activated receptor gamma as a therapeutic target to combat Type 2 diabetes |
| Q80501209 | Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia |
| Q33347137 | Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma |
| Q36223165 | Molecular-specific effects of angiotensin II antagonists: clinical relevance to treating hypertension? |
| Q24561401 | Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review |
| Q34286456 | Nonhuman primates and other animal models in diabetes research |
| Q46750257 | Norepinephrine- and epinephrine-deficient mice gain weight normally on a high-fat diet. |
| Q35204071 | Nutrigenetics: where next for the foods industry? |
| Q43050364 | Obesity and insulin resistance-related changes in the expression of lipogenic and lipolytic genes in morbidly obese subjects. |
| Q37464644 | On the mechanism for PPAR agonists to enhance ABCA1 gene expression |
| Q35215073 | Oncogenic steroid receptor coactivator-3 is a key regulator of the white adipogenic program |
| Q55457391 | Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas. |
| Q36465006 | PPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility. |
| Q46314621 | PPAR-gamma-independent inhibitory effect of rosiglitazone on glucose synthesis in primary cultured rabbit kidney-cortex tubules. |
| Q25255001 | PPAR-gamma: a thrifty transcription factor |
| Q28507952 | PPARalpha governs glycerol metabolism |
| Q28574968 | PPARgamma agonism increases rat adipose tissue lipolysis, expression of glyceride lipases, and the response of lipolysis to hormonal control |
| Q37215869 | PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease |
| Q35200033 | PPARgamma and metabolism: insights from the study of human genetic variants |
| Q43264778 | PPARgamma expression after a high-fat meal is associated with plasma superoxide dismutase activity in morbidly obese persons. |
| Q36063081 | PPARgamma in human and mouse physiology |
| Q50709371 | PPARγ activation regulates lipid droplet formation and lactate production in rat Sertoli cells. |
| Q44612931 | PPARγ activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes |
| Q47633405 | Peroxisome proliferator activated receptor (PPAR)-gamma concentrations in childhood obesity |
| Q43182141 | Peroxisome proliferator-activated receptor gamma depletion stimulates Nox4 expression and human pulmonary artery smooth muscle cell proliferation |
| Q36018557 | Peroxisome proliferator-activated receptor gamma: the more the merrier? |
| Q34165847 | Peroxisome proliferator-activated receptor-gamma: too much of a good thing causes harm |
| Q33993320 | Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective |
| Q37053886 | Pharmacology and new perspectives of angiotensin II receptor blocker in prostate cancer treatment |
| Q92084186 | Pioglitazone improves phagocytic activity of liver recruited macrophages in elderly mice possibly by promoting glucose catabolism |
| Q46755499 | Placental restriction of fetal growth decreases IGF1 and leptin mRNA expression in the perirenal adipose tissue of late gestation fetal sheep. |
| Q42483651 | Plasminogen activator inhibitor-1 modulates adipocyte differentiation. |
| Q50988205 | Pleiotropic effects of thiazolidinediones: implications for the treatment of patients with type 2 diabetes mellitus. |
| Q34797066 | Polyunsaturated Fatty Acids Modulate the Association between PIK3CA-KCNMB3 Genetic Variants and Insulin Resistance |
| Q44414175 | Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-γ expression in splenic T cells |
| Q85661680 | Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure |
| Q35933720 | Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system |
| Q48375562 | Protective effect of telmisartan on neurovascular unit and inflammasome in stroke-resistant spontaneously hypertensive rats. |
| Q97644595 | Redox Regulation of PPARγ in Polarized Macrophages |
| Q35731006 | Regulation of SREBPs by Sphingomyelin in Adipocytes via a Caveolin and Ras-ERK-MAPK-CREB Signaling Pathway |
| Q39548383 | Regulation of androgen receptor expression through angiotensin II type 1 receptor in prostate cancer cells |
| Q42961710 | Relationship among superoxide-related enzyme, PPARs, and endothelium-dependent relaxation in murine aortas previously organ-cultured in high-glucose conditions |
| Q36020654 | Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms |
| Q28299087 | Retinoid X receptors: X-ploring their (patho)physiological functions |
| Q36426752 | Role of the peroxisome proliferator-activated receptors, adenosine monophosphate-activated kinase, and adiponectin in the ovary |
| Q36581133 | Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes. |
| Q51346715 | SIRT1 interacts with metabolic transcriptional factors in the pancreas of insulin-resistant and calorie-restricted rats. |
| Q36772301 | Selective Modulators of PPAR-gamma Activity: Molecular Aspects Related to Obesity and Side-Effects |
| Q35860302 | Selective targeting of PPARγ by the natural product chelerythrine with a unique binding mode and improved antidiabetic potency |
| Q42437036 | Silencing Jnk1 and Jnk2 accelerates basal lipolysis and promotes fatty acid re-esterification in mouse adipocytes |
| Q24303857 | Sirtuin functions in health and disease |
| Q36911415 | Sirtuins: the 'magnificent seven', function, metabolism and longevity |
| Q37683351 | Slit diaphragm protein Neph1 and its signaling: a novel therapeutic target for protection of podocytes against glomerular injury |
| Q40650094 | Soy Isoflavones Exert Antidiabetic and Hypolipidemic Effects through the PPAR Pathways in Obese Zucker Rats and Murine RAW 264.7 Cells |
| Q39447694 | Stimulation of glucose uptake and improvement of insulin resistance by aromadendrin |
| Q27677426 | Structural basis for telmisartan-mediated partial activation of PPAR gamma |
| Q42478364 | Study of a new PPARgamma2 promoter polymorphism and haplotype analysis in a French population |
| Q42829800 | Suppression of PPAR-gamma attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes |
| Q27649827 | T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor gamma binding properties |
| Q91897242 | TGF-β in fibrosis by acting as a conductor for contractile properties of myofibroblasts |
| Q80101963 | Telmisartan, an angiotensin II type 1 receptor blocker, controls progress of nonalcoholic steatohepatitis in rats |
| Q37955284 | Telmisartan: just an antihypertensive agent? A literature review |
| Q38788726 | The Androgen Receptor Regulates PPARγ Expression and Activity in Human Prostate Cancer Cells |
| Q42007043 | The Effect of PPARalpha, PPARdelta, PPARgamma, and PPARpan Agonists on Body Weight, Body Mass, and Serum Lipid Profiles in Diet-Induced Obese AKR/J Mice |
| Q42818891 | The effect of plasminogen activator inhibitor-1 -675 4G/5G polymorphism on PAI-1 gene expression and adipocyte differentiation |
| Q36328060 | The effects of old, new and emerging medicines on metabolic aberrations in PCOS. |
| Q35592289 | The human sirtuin family: evolutionary divergences and functions. |
| Q38139508 | The importance of synthetic drugs for type 2 diabetes drug discovery |
| Q38727651 | The peroxisome proliferator-activated receptors under epigenetic control in placental metabolism and fetal development. |
| Q37029352 | The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implications |
| Q37596557 | The role of sirtuins in the control of metabolic homeostasis |
| Q37848841 | The safety of thiazolidinediones |
| Q33748280 | Thermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma |
| Q39239818 | Thermodynamics in cancers: opposing interactions between PPAR gamma and the canonical WNT/beta-catenin pathway |
| Q35606054 | Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS). |
| Q46275858 | Tissue-specific postprandial clearance is the major determinant of PPARgamma-induced triglyceride lowering in the rat. |
| Q38344277 | Transcription factors and cognate signalling cascades in the regulation of autophagy |
| Q48177278 | Treatment with Parkinsonia aculeata combats insulin resistance-induced oxidative stress through the increase in PPARγ/CuZn-SOD axis expression in diet-induced obesity mice. |
| Q91639799 | Two antibacterial and PPARα/γ-agonistic unsaturated keto fatty acids from a coral-associated actinomycete of the genus Micrococcus |
| Q46830855 | Up-regulation of PPARgamma in myocardial infarction |
| Q65001385 | Withaferin A inhibits adipogenesis in 3T3-F442A cell line, improves insulin sensitivity and promotes weight loss in high fat diet-induced obese mice. |
| Q90214862 | p-21 Activated Kinase as a Molecular Target for Chemoprevention in Diabetes |
| Q37093109 | α-linolenic acid inhibits human renal cell carcinoma cell proliferation through PPAR-γ activation and COX-2 inhibition |
Search more.